Relation of Health-Related Quality of Life with Glycemic Control and Use of Diabetes Technology in Children and Adolescents with Type 1 Diabetes: Results from a National Population Based Study
Table 1
Demographic characteristics, clinical profiles, and treatment regimens of all children with type 1 diabetes registered in the Norwegian Childhood Diabetes Registry’s (NCDR) annual registration in 2017, stratified by participating and nonparticipating children and parents.
All registered children (NCDR annual registration)
Children 10–17 years ()
Children <10 years ()
Children participating
Children not participating
Parents participating
Parents not participating
Parents participating
Parents not participating
Valid
2,725
1,019
1,040
1,070
989
371
295
Proportion
49.5%
50.5%
52.0%
48.0%
55.7%
44.3%
HbA1c
mmol/mol
61.8
63.3
63.8
0.49
63.2
63.9
0.22
56.4
56.0
0.61
%
7.8
7.9
8.0
7.9
8.0
7.3
7.3
Age
Years
12.6
14.1
14.6
<0.05
14.0
14.7
<0.05
7.3
7.2
0.64
Diabetes duration
Years
5.1
5.6
6.0
<0.05
5.5
6.1
<0.05
3.0
3.1
0.30
Females
%
45.7
41.9
50.4
<0.05
41.8
51.0
<0.05
44.2
44.1
1.00
Insulin pump users
%
74.2
73.7
71.1
0.22
73.0
71.8
0.61
79.1
80.3
0.78
CGM users
%
51.7
45.7
44.9
0.74
45.8
44.7
0.68
71.7
70.0
0.68
Group differences between participants and nonparticipants were tested using two-sample -tests (HbA1c, age, and diabetes duration) or chi-squared tests (gender, pump use, and CGM use).
